Andrew I-Wei Chin, M.D.
Health Sciences Clinical Professor
Interim Chief of Nephrology
To see if Andrew I-Wei Chin is accepting new patients, or for assistance finding a UC Davis doctor, please call 800-2-UCDAVIS (800-282-3284).
Locations and Contact
Lawrence J. Ellison Ambulatory Care Center
Nephrology Clinic
4860 Y St.
Sacramento, CA 95817
Phone: 916-734-3761
Additional Numbers
Physician Referrals
Philosophy of Care
People can get very anxious when they learn that they have kidney disease. Kidney disease is often chronic, silent and difficult to understand. My goals for care are centered around building that understanding in a partnership with individuals, and then applying evidenc-based treatments in a practical and holistic manner.
Clinical Interests
Dr. Chin is a nephrologist offering care for adults with kidney diseases. This includes the care of those who are on dialysis.
Research/Academic Interests
Dr. Chin's research interests focus on outcomes for those with advanced chronic kidney disease and the transition of care for the individuals who need dialysis. He is also interested in aspects of hemodialysis care, particularly to maintaining residual kidney function.
Division
Nephrology
Undergraduate School
B.A., Ecology and Evolutionary Biology, Princeton University, Princeton NJ 1991
Medical School
M.D., UC Davis School of Medicine, Sacramento CA 1995
Internship
Internal Medicine, Scripps Mercy Hospital and Medical Center, San Diego CA 1995-1996
Residency
Internal Medicine, Scripps Mercy Hospital and Medical Center, San Diego CA 1996-1998
Residency
Chief Resident - Internal Medicine, Scripps Mercy Hospital and Medical Center, San Diego CA 1998-1999
Fellowship
Nephrology, UC Davis School of Medicine, Sacramento CA 1999-2001
Resident of the Year, Teaching Award, Scripps Mercy Hospital and Medical Center, 1998
Wang J, Nguyen TA, Chin AI, Ross JL. Treatment of tunneled dialysis catheter malfunction: revision versus exchange. J Vasc Access. 2016 Jul 12;17(4):328-32. doi:10.5301/jva.5000533. Epub 2016 Jun 1. PMID:27312750.
Chin AI, Nguyen TA, Dinesh KP, Morfin JA. Late acceleration of glomerular filtration rate decline is a risk for hemodialysis catheter use in patients with established nephrology chronic kidney disease care. Hemodial Int. 2015 Jul;19(3):379-85. doi:10.1111/hdi.12253. Epub 2014 Dec 5. PMID:25477069.
Kaysen GA, Chin A. If oxidative stress is an appropriate and specific target, what reagent should we choose? J Am Soc Nephrol. 2014 Mar;25(3):427-9. doi:10.1681/ASN.2013111178. Epub 2013 Dec 19. PMID:24357667.
Chin AI, Dalrymple LS. Ideal cardiovascular health and progression of CKD: perhaps not so "simple". J Am Soc Nephrol. 2013 Jun;24(7):1031-3. doi:10.1681/ASN.2013040388. Epub 2013 May 23. PMID:23704287.
Chang DN, Dager WE, Chin AI. Removal of dabigatran by hemodialysis. Am J Kidney Dis. 2013 Mar;61(3):487-9. doi:10.1053/j.ajkd.2012.08.047. Epub 2012 Dec 5. PMID:23219111.
Chin AI, Raffo WR, Yang X, Madison JR. Evolution of hemodialysis access resistance: a longitudinal 5-year model using functional principal components analysis. Int J Artif Organs. 2009 Dec;32(12):864-71. doi:10.1177/039139880903201205. PMID:20037891.
Chin AI. Renal acid-base balance and renal tubular acidosis. Stoller ML, Meng MV (eds). Urinary Stone Disease: the practical guide to medical and surgical management, The Humana Press Inc. 2007;2(8):121-156.
Chin AI, Yeun JY. Encapsulating peritoneal sclerosis: an unpredictable and devastating complication of peritoneal dialysis. Am J Kidney Dis. 2006 Apr;47(4):697-712. doi:10.1053/j.ajkd.2005.12.049. PMID:16564950.
Morfin JA and Chin AI. Urinary Oxalate Crystals in Ethylene Glycol Intoxication. New England J Med. 2005 Jan;353(24):e21. doi:10.1056/NEJMicm050183.
Chin AI, Chang W, Fitzgerald JT, Schanzer A, Perez RV, McVicar JP, Troppmann C. Intra-access blood flow in patients with newly created upper-arm arteriovenous native fistulae for hemodialysis access. Am J Kidney Dis. 2004 Nov;44(5):850-8. PMID:15492951.